Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      AVAILABLE
      Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)
      Description

      The protocol is designed to provide access to patients to the Clinimacs® CD34 TCRαβ system to prepare cells for an unlabeled indication using an HLA-compatible related or unrelated donor for allogenic transplant.

      Conditions
      Transplant-Related DisorderGVH - Graft Versus Host Reaction
      Talk to us